To hear about similar clinical trials, please enter your email below
Trial Title:
Effects of Dexamethasone on Common Bile Duct Cannulation Time
NCT ID:
NCT05945797
Condition:
Common Bile Duct Diseases
Common Bile Duct Calculi
Common Bile Duct Stricture
Common Bile Duct Neoplasms
Common Bile Duct Dilatation
Conditions: Official terms:
Bile Duct Neoplasms
Common Bile Duct Neoplasms
Bile Duct Diseases
Gallstones
Common Bile Duct Diseases
Calculi
Dexamethasone
Conditions: Keywords:
ERCP, Steroids, Dexamethasone, CBD cannulation time
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Intervention:
Intervention type:
Drug
Intervention name:
Dexamethasone 4mg
Description:
An injection of 4mg of dexamethasone will be given to patients approximately 2 to 4 hours
prior to the procedure of ERCP.
Arm group label:
Dexa Arm
Arm group label:
NS Arm
Other name:
steroids
Summary:
The main aim of this clinical trial is to evaluate the effects of dexamethasone on common
bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP)
in patients with biliary pathologies. The study will also study the effects of
dexamethasone on total procedure time and total fluoroscopy time during ERCP.
Participants will be divided into two groups, treatment group and placebo group. Patients
in treatment group will receive dexamethasone and those in placebo group will be given
normal saline before undergoing ERCP. The results in both groups will be compared to
determine the effects of dexamethasone.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age: 18 years or above
- Both genders, male and female patients
Exclusion Criteria:
- Age younger than 18 years or below
- Pregnant females
- Pre existing stent in CBD or pancreatic duct
- Previous history of ERCP
- Patients with billroth II surgery
- Anatomical abnormalities
- Lack of competence in patients
- Roux en Y gastric bypass
- Patients with contra indications for steroids like DM
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Gujranwala Medical College Hospital
Address:
City:
Gujranwala
Zip:
52070
Country:
Pakistan
Status:
Recruiting
Contact:
Last name:
Najam us Sehar Saeed, FCPS
Phone:
+923026100643
Email:
nawaeziest@yahoo.com
Start date:
August 1, 2023
Completion date:
November 2023
Lead sponsor:
Agency:
Gujranwala medical college District Headquarters Hospital, Gujranwala
Agency class:
Other
Source:
Gujranwala medical college District Headquarters Hospital, Gujranwala
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05945797
